More on PHAR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $10.81 |
|
|||
| Open | $10.82 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $11.69 | ||||
| Day Low | $10.65 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 39,070 | ||||
- Form 6-K Pharming Group N.V. For: Sep 11
- FDA approves Pharming's Joenja for children ages 4 to 11 with APDS
- FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
- Pharming Group to participate in September investor conferences
- Form 6-K Pharming Group N.V. For: Aug 13
- Pharming Group (PHAR) PT Raised to $38 at Canaccord
- Pharming Group (PHAR) PT Lowered to $39 at Oppenheimer
- Pharming Group N.V. (PHAR) Misses Q2 EPS by 6c
- Form 6-K Pharming Group N.V. For: Jul 30
- Form 6-K Pharming Group N.V. For: Jun 04
Entities mentioned with PHAR
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
